MyAverix Finance
F · Healthcare
Anixa Biosciences Inc (CY71)
Biotechnology
Anixa Biosciences Inc (CY71) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-28, reported market cap is $83.38M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CY71
Anixa Biosciences Inc (CY71) — FAQ
What is Anixa Biosciences Inc's market cap?
Anixa Biosciences Inc (CY71) has a reported market cap of $83.38M (data as of 2026-03-28).
What is CY71's P/E ratio?
The price-to-earnings (P/E) ratio for Anixa Biosciences Inc (CY71) is 18.00 (data as of 2026-03-28).
Does Anixa Biosciences Inc pay a dividend?
Dividend yield is not available in the current snapshot for Anixa Biosciences Inc (CY71). Check the MyAverix Finance app for the latest dividend data.
What sector is Anixa Biosciences Inc in?
Anixa Biosciences Inc (CY71) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CY71 listed on?
CY71 is listed on F.
What is Anixa Biosciences Inc's net margin?
Anixa Biosciences Inc (CY71) reports a net margin of 0.0% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.